Obama's budget shortens biologic exclusivity, cuts drug spending

04/11/2013 | Medical Marketing & Media · In-PharmaTechnologist.com

President Barack Obama's budget proposal would reduce biologic exclusivity from 12 years to seven, and it includes more than $160 billion in reduced spending that affects drugmakers. The plan would increase discounts for branded medications under Medicare Part D and reduce prices for drugs for people eligible for both Medicare and Medicaid.

View Full Article in:

Medical Marketing & Media · In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ